Vivos Therapeutics Inc

NASDAQ:VVOS  
1.85
+0.28 (+17.83%)
Earnings Announcements

Vivos Therapeutics Reports Fourth Quarter And Full Year 2021 Financial Results And Operational Update

Published: 03/31/2022 20:57 GMT
Vivos Therapeutics Inc (VVOS) - Vivos Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Update.
Q4 Revenue Rose 33 Percent to $4.4 Million.
Revenue is expected to be $3.81 Million
Adjusted EPS is expected to be -$0.28

Next Quarter Revenue Guidance is expected to be $4.16 Million
Next Quarter EPS Guidance is expected to be -$0.27

More details on our Analysts Page.